Dentsply Sirona reported a decrease in net sales of $936 million for Q2 2025, down 4.9% from the previous year. Adjusted EPS was $0.52, with a net loss per share of ($0.22). The company executed a $550 million debt offering and reaffirmed its FY25 outlook. Leadership transition announced with Dan Scavilla appointed CEO and Matt Garth as CFO.

Despite a decrease in net sales, Dentsply Sirona saw margin expansion in Q2 2025, with a GAAP gross margin of 52.4%. The Company reported a net loss of ($45) million and adjusted EBITDA margin of 21.1%. Operating cash flow was $48 million, with dividends totaling $64 million in the first half of 2025. The Company issued $550 million in notes to repay debt.

In Q2 2025, Dentsply Sirona recorded a non-cash charge of ($214) million for impairments in the Orthodontic and Implant Solutions segments. This was due to tariffs and lower volumes in implants and prosthetics. The 2025 outlook maintains net sales between $3.60 billion to $3.70 billion and an adjusted EPS range of $1.80 to $2.00, reflecting the current state of tariffs and trade policy.

The Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, payable on October 10, 2025. A conference call and webcast will be held on August 7th, 2025, at 8:30 am ET for investors. Conference call registration is available on the Company’s website. Dentsply Sirona reported a net sales decrease of 4.9% to $936 million, with a 6.7% decrease in constant currency. They also announced a leadership transition, with Dan Scavilla appointed CEO and Matt Garth as CFO. The company executed a $550 million debt offering and reaffirmed their FY25 outlook.

Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, offering high-quality solutions for dental care. Their headquarters are in Charlotte, North Carolina, and their shares are listed on Nasdaq under the symbol XRAY. For more information, visit their website.

The company reported a GAAP gross margin of 52.4%, a GAAP net loss per share of ($0.22), and an adjusted EPS of $0.52. They also posted an adjusted gross margin of 55.9% and an adjusted EBITDA margin of 21.1%. Dentsply Sirona’s net sales for the quarter totaled $936 million, with a decrease of 4.9%.

Dentsply Sirona’s consolidated balance sheet shows total assets of $6.069 billion as of June 30, 2025, and total equity of $1.961 billion. Their consolidated statements of cash flows for the six months ended June 30, 2025, reveal net cash provided by operating activities of $55 million and a net increase in cash and cash equivalents of $87 million. The company also provided non-GAAP financial measures in their press release. In the latest financial report, net sales of $936 million decreased by 4.9%, with a 6.7% decrease in constant currency, including a 3.2% Byte sales impact. The company reported a GAAP gross margin of 52.4% and a net loss per share of ($0.22). Adjusted gross margin was 55.9%, adjusted EBITDA margin was 21.1%, and adjusted EPS was $0.52. A $550 million debt offering was executed, and the company reaffirmed its FY25 outlook. A leadership transition was announced, with Dan Scavilla appointed CEO effective August 1, 2025, and Matt Garth appointed CFO effective May 30, 2025. These Non-GAAP financial measures are provided as they are frequently used by investors and analysts to evaluate the company’s performance, excluding certain items that may impact comparability of results from period to period and may not be indicative of past or future performance. “Constant currency” is defined as reported net sales adjusted for the impact of foreign currency changes, calculated using the comparable prior period’s foreign currency exchange rates. Adjusted operating income and margin are computed by excluding business combination-related costs, restructuring-related charges, goodwill and intangible asset impairments, amortization of purchased intangible assets, and fair value and credit risk adjustments from operating income. Adjusted gross profit and margin are calculated similarly. Adjusted net income (loss) consists of net income (loss) as reported in accordance with US GAAP, adjusted to exclude the identified items and related income tax impacts. Dentsply Sirona reported a decrease in net sales of 4.9%, reaching $936 million, with a 6.7% decrease in constant currency. The company also announced a leadership transition, with Dan Scavilla as CEO and Matt Garth as CFO. Adjusted EPS was $0.52, with adjusted EBITDA margin at 21.1%. The company executed a $550 million debt offering and reaffirmed its FY25 outlook.

Net income adjustments for tax-related matters were made to normalize the effects of certain irregular items. Adjusted EBITDA and margin were calculated by excluding interest expense, net, income tax expense, and depreciation and amortization. Adjusted free cash flow and conversion were defined as important measures of financial performance.

A reconciliation of net sales change was provided by segment and geographic region. Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare were analyzed. Segment adjusted operating income for Q2 2025 was $233 million, with reconciling items expense included. A reconciliation of selected items for the quarter ended June 30, 2025, was also detailed, showing a gross profit of $523 million and adjusted non-GAAP margin of 55.9%.

For the quarter ended June 30, 2024, a similar reconciliation of selected items was made, with a gross profit of $544 million and adjusted non-GAAP margin of 55.3%. The company reported a GAAP margin of 51.9% and a diluted EPS of ($0.02). Adjusted non-GAAP items included amortization of purchased intangible assets, restructuring-related charges, and income tax-related adjustments.

Read more at GlobeNewswire: Dentsply Sirona Reports Second Quarter 2025 Results